Literature DB >> 17685833

Prevalence and construct validity of Personality Disorder Not Otherwise Specified (PDNOS).

Roel Verheul1, Anna Bartak, Thomas Widiger.   

Abstract

Personality Disorder Not Otherwise Specified (PDNOS) is one of the most frequently used Axis II diagnoses, yet explicit guidelines for its assessment are lacking. To investigate the prevalence and construct validity of various definitions of PDNOS, 1760 psychotherapy referrals were diagnosed using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV). Construct validity parameters included severity of psychiatric complaints, personality symptoms, and functional impairment. Results show that PDNOS is highly prevalent in this sample (21.6% or 70.8%, depending on whether co-occurrence with formal PD is allowed). Patients with both formal PD and PDNOS have more severe problems than those with formal PD only. In terms of severity, PDNOS takes an intermediate position between formal and no PD. For mixed PD, a cut-off of 5 criteria would yield a large (12.0%) additional PD group with a similar level of functional impairment as compared to mixed PD with a cut-off of either 10 or 15 criteria. In conclusion, the high prevalence of PDNOS warrants proportional attention in science and practice. If PDNOS is retained in DSM-V, it is recommendable to develop explicit guidelines for its assessment.

Entities:  

Mesh:

Year:  2007        PMID: 17685833     DOI: 10.1521/pedi.2007.21.4.359

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  12 in total

1.  A Systematic Review of Personality Disorders and Health Outcomes.

Authors:  Katherine L Dixon-Gordon; Diana J Whalen; Brianne K Layden; Alexander L Chapman
Journal:  Can Psychol       Date:  2015-10-15

Review 2.  Personality disorders in DSM-5: emerging research on the alternative model.

Authors:  Leslie C Morey; Kathryn T Benson; Alexander J Busch; Andrew E Skodol
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

3.  Personality traits and maladaptivity: Unipolarity versus bipolarity.

Authors:  Trevor F Williams; Leonard J Simms
Journal:  J Pers       Date:  2018-01-05

Review 4.  An Overview of the DSM-5 Alternative Model of Personality Disorders.

Authors:  Robert F Krueger; Kelsey A Hobbs
Journal:  Psychopathology       Date:  2020-07-09       Impact factor: 1.944

5.  Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention.

Authors:  Maria Casagrande; Andrea Marotta; Valeria Canepone; Alfredo Spagna; Caterina Rosa; Giancarlo Dimaggio; Augusto Pasini
Journal:  Cogn Process       Date:  2017-03-11

Review 6.  Disorders without borders: current and future directions in the meta-structure of mental disorders.

Authors:  Natacha Carragher; Robert F Krueger; Nicholas R Eaton; Tim Slade
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-01-04       Impact factor: 4.328

7.  The Brave New World of Personality Disorder-Trait Specified: Effects of Additional Definitions on Coverage, Prevalence, and Comorbidity.

Authors:  Lee Anna Clark; Emily N Vanderbleek; Jaime L Shapiro; Hallie Nuzum; Xia Allen; Elizabeth Daly; Thomas J Kingsbury; Morgan Oiler; Eunyoe Ro
Journal:  Psychopathol Rev       Date:  2015

Review 8.  A unifying perspective on personality pathology across the life span: developmental considerations for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders.

Authors:  Jennifer L Tackett; Steve Balsis; Thomas F Oltmanns; Robert F Krueger
Journal:  Dev Psychopathol       Date:  2009

9.  Avoidant personality disorder versus social phobia: the significance of childhood neglect.

Authors:  Ingeborg Eikenaes; Jens Egeland; Benjamin Hummelen; Theresa Wilberg
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

10.  Excess cause-specific mortality in out-patients with personality disorder.

Authors:  Charlotte Björkenstam; Emma Björkenstam; Bengt Gerdin; Lisa Ekselius
Journal:  BJPsych Open       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.